Argyle Capital Management, LLC
โขCIK: 1321194โขFiling: Q4 2025
**Argyle Capital Management Inc.** manages $300M across a diversified portfolio of 137 positions. The firm maintains significant exposure to technology and healthcare leaders, highlighted by a $13.1M stake in Microsoft (MSFT) and $11.9M in Eli Lilly (LLY). Other key allocations include $9.5M in JPMorgan Chase (JPM) and $8.8M in Merck (MCK). This concentration suggests a tactical focus on established mega-cap names across defensive and growth sectors.
Total AUM
$299.5M
QoQ Performance
+3.6%
Positions
137
Top 10 Concentration
28.2%
Latest Filing
Q4 2025
Top Holdings Allocation
MSFT4.4%
LLY4.0%
JPM3.2%
MCK2.9%
RTX2.5%
PNC2.4%
IBM2.3%
MRK2.2%
๐ Biggest Buys
๐ Biggest Sells
Sector Breakdown
Other42.6%
Healthcare15.1%
Technology14.0%
Financial9.5%
Industrial9.0%
Energy2.5%
Utilities2.3%
Communication2.0%
๐ช Exited Positionssold since Q3 2025
โ
Labcorp Holdings Inc
SOLD
$222.8K
Changes from Q3 2025
NEW4 new positions
โ33 increased
โ23 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023